MedTrace Logo

Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients

NCT04405024 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2500

Last updated 2025-07-03

No results posted yet for this study

Summary

The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025.

The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

Hepatitis C testing

Hepatitis C Screening

Sponsors & Collaborators

  • Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux

    collaborator UNKNOWN

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2024-06-21
Completion
2026-06-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405024 on ClinicalTrials.gov